LOGIN  |  REGISTER
Recursion

Recent Insider Transactions - Athira Pharma (NASDAQ: ATHA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ATHA Athira Pharma
Litton Mark James / director, officer: President and CEO
10/03/2024
Buy
$0.43
325,000
$138K
325,000
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Buy
$0.45
37,077
$17K
37,077
NASDAQ ATHA Athira Pharma
San Martin Javier / officer: CHIEF MEDICAL OFFICER
10/01/2024
Buy
$0.45
140,000
$63K
140,000
NASDAQ ATHA Athira Pharma
CHURCH KEVIN / officer: CHIEF SCIENTIFIC OFFICER
10/01/2024
Buy
$0.45
110,000
$49K
110,000
NASDAQ ATHA Athira Pharma
Worthington Mark / officer: General Counsel and CCO
10/01/2024
Buy
$0.45
110,000
$49K
110,000
NASDAQ ATHA Athira Pharma
Litton Mark James / director, officer: President and CEO
10/03/2024
Buy
$0.45
325,000
$146K
325,000
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$10.64
40,600
$432K
0
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$17.00
18,915
$322K
0
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$22.22
1,085
$24K
0
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$21.15
10,000
$212K
0
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$12.38
13,000
$161K
0
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$3.37
56,750
$191K
0
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
10/01/2024
Sell
$3.26
74,154
$242K
0
NASDAQ ATHA Athira Pharma
Gengos Andrew / officer: CFO and Chief Business Officer
09/05/2024
Sell
$0.57
1,272
$720
97,532
NASDAQ ATHA Athira Pharma
Lenington Rachel / officer: COO and CDO
09/05/2024
Sell
$0.57
2,525
$1K
20,870
NASDAQ ATHA Athira Pharma
CHURCH KEVIN / officer: CHIEF SCIENTIFIC OFFICER
09/05/2024
Sell
$0.57
2,525
$1K
92,684
NASDAQ ATHA Athira Pharma
Worthington Mark / officer: GENERAL COUNSEL
09/05/2024
Sell
$0.57
2,525
$1K
51,927
NASDAQ ATHA Athira Pharma
Litton Mark James / director, officer: President and CEO
09/05/2024
Sell
$0.57
5,032
$3K
159,365

COPYRIGHT ©2023 HEALTH STOCKS HUB